BCBSRI is updating preferred product selections for four Commercial medical drug categories. Related...

Did you know that we offer a fast and seamless electronic way to submit requests for pharmacy drug t...

BCBSRI and Prime Therapeutics will transition from SimplicityRx to JudiRx to administer the Medicare...

BCBSRI and Prime Therapeutics will transition from SimplicityRx to JudiRx to administer the Medicare...

Large Group and Small Group Markets Formulary The information at the link above is effective as of O...

BCBSRI would like to inform providers of an upcoming change in coverage for the medications listed b...

Large Group and Small Group Markets Formulary This information is effective as of October 1, 2026 an...

BCBSRI would like to inform providers of an upcoming change in coverage for the medications listed b...

Effective September 1, 2026, iDose TR (J7355) and Durysta (J7351) will require prior authorization u...

BCBSRI would like to inform providers of an upcoming change in coverage for the medications listed b...

Effective September 1, 2026, iDose TR (J7355) and Durysta (J7351) will require prior authorization u...

Effective September 1, 2026 iDose TR (J7355) and Durysta (J7351) will require a prior authorization ...

The following drugs will require PA effective April 1, 2026...

Large Group and Small Group Markets FormularyThe information at the link above is effective as of Ap...

The following brand name and generic drugs with preferred alternatives be excluded from coverage eff...

The following drugs will require PA effective March 1, 2026 The following drugs are new to the marke...

Effective February 26, 2026 Apretude® will transition from the medical benefit to the pharmacy (Rx) ...

Large Group and Small Group Markets FormularyThe information in the link above is effective as of Ap...

The following brand name and generic drugs with preferred alternatives be excluded from coverage eff...

The following drugs will require PA effective February 1, 2026 RXGenericHCPCS CodeProductEffective D...

The following drugs will require PA effective January 1, 2026...

The following drugs are new to the market effective December 1, 2025 and all require prior authoriza...

The following drugs will require Prior Authorization beginning on October 1, 2025 for Commercial and...

The following drugs will require Prior Authorization beginning on October 1, 2025 for Commercial and...